Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 117.05
-1.41 %
$ 11.7 B
Market Cap
35.58
P/E
NBIX - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities NBIX - Neurocrine Biosciences, Inc.
-127 M
LAST VALUE
15.38%
2 YEAR CAGR
9.69%
5 YEAR CAGR
-1.87%
10 YEAR CAGR